Form 4: Avalo Therapeutics Director Exercises Restricted Stock Units
SEC Form 4
Director Mitchell Chan exercised restricted stock units of Avalo Therapeutics, Inc. on March 28, 2025, converting them into 3,167 shares of common stock.
Summary
- On March 28, 2025, Mitchell Chan, a director of Avalo Therapeutics, Inc., exercised 3,167 restricted stock units (RSUs).
- These RSUs converted into 3,167 shares of Avalo Therapeutics common stock on a one-for-one basis.
- Following the transaction, Chan directly owns 6,333 derivative securities.
- The RSUs were part of a grant of 9,500 RSUs awarded on August 13, 2024, vesting in three equal installments on March 28, 2025, March 28, 2026, and March 28, 2027, contingent upon continued service.
Sentiment
Score: 5
Explanation: This is a routine transaction related to executive compensation and doesn't indicate a particularly positive or negative outlook for the company.
Industry Context
This is a standard Form 4 filing, reflecting insider transactions in a publicly traded company. Such filings are common and provide transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction increases the number of outstanding shares, which could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| August 13, 2024 | Reporting Person was granted 9,500 restricted stock units |
| March 28, 2025 | Date of transaction where 3,167 restricted stock units vested and converted to common stock |
| April 01, 2025 | Date of signature for the Form 4 filing |
| March 28, 2026 | Next vesting date for 1/3 of the restricted stock units |
| March 28, 2027 | Final vesting date for 1/3 of the restricted stock units |
Keywords
Form 4, Beneficial Ownership, Restricted Stock Units, AVTX, Avalo Therapeutics, Director, Mitchell Chan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.